12月27日,昭衍新药今日收盘16.96元,上涨0.24%,最新市净率1.59。截至2024年三季报,共有10家机构持仓昭衍新药,其中基金9家、其他1家,合计持股数3588.78万股,持股市值6.48亿元。北京昭衍新药研究中心股份有限公司主营业务专注于药物全生命周期的安全性评价和监测服务,其药物临床前研究服务为公司的核心业务,主要内容包括药物非临床安全性评价服务、药效学研究服务、动物药代动力学研究...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.